Adragos Hub

Stay up-to-date with our latest news, blog articles, videos, and event announcements. Learn from business success stories and gain access to valuable e-books and resources.

Blog

Blog

->
News

News

->
Events

Events

->
Videos

Videos

->
Resources

Resources

->

Non-Sterile Liquids & Semi-Solids at Adragos Leipzig

At Adragos Leipzig, quality is at the heart of everything we do. We specialise in non-sterile liquids, such as cough syrups and other liquid medicines, and non-sterile semi-solids. While these products do not need to be made in aseptic conditions, […]

High-Quality Semisolid: Manufacturing at Adragos Leipzig

Semisolid, or semi-solid dosage form, is a topical or transdermal product with a consistency between a liquid and a solid. They include creams, ointments, gels, and pastes. Systems designed to deliver active pharmaceutical ingredients (APIs) to or through the skin […]

Product testing: a critical part of the pharma manufacturing process

Analytical testing is a critical function for any company involved in pharmaceutical manufacturing. The Analytical Department truly sits at the heart of what we do; bringing together science, quality, and compliance to make sure every product released is safe and […]

Steriles: An Ever-Evolving Market  

The pharmaceutical industry is always evolving and advancing, and the world of sterile filling is no exception. Here at Adragos, steriles are one of our core competencies, and we keep a keen interest in how the market is progressing to […]

Aseptic filling: scaling up and sterility assurance 

Patients rely on pharmaceutical manufacturers to ensure that the medicines they are given are safe. For injectable products, aseptic filling is key, and facilities such as Adragos Jura must follow regulatory guidelines extremely carefully.  The product must be totally protected […]

Understanding the HPAPI sector

Recently, Konstantinos Apostolou, R&D senior manager at our Athens Development facility, was featured in European Pharmaceutical Manufacturer, where he explored the rapid rise of highly potent active pharmaceutical ingredients (HPAPIs). The market is valued at $185.5 billion in 2024 and […]

Subscribe to our newsletter!

Get notified on our latest news.